HealthEx: Patient Preference And Consent Management Company Raises $14 Million

By Amit Chowdhry ● Yesterday at 1:00 PM

HealthEx – a team of healthcare and technology veterans building a global consumer preference and consent platform for healthcare to unlock data access – recently launched and announced $14 million in Seed and Series A funding. The company’s funding round was led by General Catalyst, with participation by Electric Capital.

HealthEx’s latest funding will drive the expansion of its AI-powered platform. And the company will scale development to simplify integrating the patient voice across all healthcare activities, while simultaneously automating the manual burden of security and compliance processes needed in the increasingly complex landscape of health data access.

HealthEx’s solution is one of the first AI platforms that enables healthcare organizations to easily create, collect, and enforce patient consent and preferences, and allow health systems to fulfill their roles as trusted stewards of patient data. And healthcare organizations can enhance the patient experience, boost operational efficiency, increase compliance, and unlock new data licensing opportunities.

Healthcare organizations are facing new complexities in data use and licensing. Patients and healthcare organizations need a more streamlined, transparent approach to ensure trust and compliance in today’s data-driven landscape. Built in collaboration with leading health systems, the HealthEx solution will manage massive amounts of unstructured content in lengthy consents, legal contracts, and other policy documents governing data access and transform this content into automated, enforceable workflows.

HealthEx transforms consent from a one-dimensional process that patients find confusing and healthcare organizations struggle to granularly enforce into a comprehensive platform offering. And AI agents help clinical staff generate consents for different use cases during the care journey to reduce manual effort.

Data and compliance administrators can programmatically enforce granular consents and utilize AI-baed risk assessments of existing consents, giving them confidence that preferences and all sources of data policy are followed through via HealthEx’s APIs, gateways, and secure data vaults.

HealthEx complements national efforts in health data interoperability to enable greater patient input in data movement, including TEFCA’s individual access services. Showcasing the company’s commitment to interoperability, HealthEx makes patient and health system data preferences and policies available to ecosystem collaborators in formats compatible with emerging HL7 Consent FHIR standards.

HealthEx was hatched by General Catalyst and it is deeply integrated with the VC firm’s Health Assurance network. And the HealthEx solution is available today.

KEY QUOTES:

“As health systems embark on a new era of AI-driven care, one area ripe for disruption is analog consent and data access processes that leave consumers unsure of their choices and health systems open to security and compliance risks. By enabling ethical access to proprietary health data, HealthEx can help organizations maintain patient trust and transform their operations to generate greater value through their health data.”

– Stephen Klasko, MD, special advisor with General Catalyst and former CEO of Thomas Jefferson Health

“As healthcare organizations face new complexities in data use and licensing, it’s clear that both patients and providers need a more streamlined, transparent solution to ensure trust and compliance in today’s data-driven landscape. We allow healthcare organizations to manage this data effectively while giving patients more control over their healthcare decisions and creating a more transparent process. Our vision is to manage patient preferences and consent for individuals across every healthcare touchpoint with a unified experience for preferences, consent, and data access management.”

– Priyanka Agarwal, MD, MBA, co-founder and CEO of HealthEx and a healthcare veteran with experience in clinical medicine, digital health, and the life sciences

Exit mobile version